You have 9 free searches left this month | for more free features.

Non-invasive bladder cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

Not yet recruiting
  • High-risk Non-muscle Invasive Bladder Cancer
  • (no location specified)
Oct 25, 2023

Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

Completed
  • Urinary Bladder Cancer
  • +4 more
  • Neutrophil to lymphocyte ratio
  • Cairo, Egypt
    Ain Shams university
Jul 15, 2023

Non-muscle Invasive Bladder Cancer Trial in Chengdu (RC48-ADC)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • Chengdu, Sichuan, China
    West China Hospital
Aug 10, 2023

Non-muscle-invasive Bladder Cancer Trial (Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • Cystoscopy
  • +2 more
  • (no location specified)
Apr 4, 2023

Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Apr 11, 2023

    Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

    Recruiting
    • Non Muscle Invasive Bladder Cancer
    • N803 plus Bacillus Calmette-Guerin (BCG)
    • Honolulu, Hawaii
      Island Urology
    Aug 7, 2023

    Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)

    Recruiting
    • Bladder Cancer
    • Pseudomonas aeruginosa
    • Jinan, Shandong, China
      Qilu hospital
    Jul 26, 2023

    BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder

    Recruiting
    • Bladder Cancer
      • Little Rock, Arkansas
      • +2 more
      Aug 6, 2023

      Analytical Specificity of Bladder EpiCheck Test in Healthy

      Completed
      • Non Muscle Invasive Bladder Cancer
      • Non-Muscle Invasive Bladder Urothelial Carcinoma
      • Bladder EpiCheck
      • San Antonio, Texas
        Urology San Antonio
      Sep 3, 2023

      Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

      Not yet recruiting
      • Non-Muscle- Invasive Bladder Cancer
      • Durvalumab
      • BCG
      • (no location specified)
      Jul 5, 2023

      Non-muscle Invasive Bladder Cancer Trial (TARA-002)

      Not yet recruiting
      • Non-muscle Invasive Bladder Cancer
      • TARA-002
      • (no location specified)
      Jul 14, 2023

      Urine-based Molecular Testing vs Cystoscopy for Surveillance of

      Not yet recruiting
      • Non-muscle Invasive Bladder Cancer
      • +2 more
      • CxBladder Monitor
      • Cystoscopy
      • Scottsdale, Arizona
      • +2 more
      Nov 14, 2023

      Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)

      Not yet recruiting
      • Non-Muscle Invasive Bladder Cancer
      • HER2
      • (no location specified)
      Jul 16, 2023

      Non-muscular Invasive Bladder Cancer Trial in Changsha (BCG for therapeutic use)

      Not yet recruiting
      • Non-muscular Invasive Bladder Cancer
      • BCG for therapeutic use
      • Changsha, China
        Hunan Cancer Hospital
      Oct 20, 2023

      Uromonitor asBiomarker for Optimization of NMIBC Management by

      Not yet recruiting
      • Non-muscle-invasive Bladder Cancer
        • (no location specified)
        May 9, 2023

        Mood Alterations in Non-Muscle Invasive Bladder Cancer Treated

        Recruiting
        • Non-Muscle Invasive Bladder Cancer
        • Questionnaires
        • +4 more
        • Washington, District of Columbia
          Sibley Memorial Hospital
        Jan 17, 2023

        Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
        • +2 more
        • PDD-TURBT with hexaminolevulinate (Hexvix®)
        • Power Led Saphira (TM) from KARL STORZ
        • (no location specified)
        Jul 24, 2023

        Bladder Cancer Trial in Roskilde (Urine test)

        Recruiting
        • Bladder Cancer
          • Roskilde, Denmark
            Zealand University Hospital
          Oct 5, 2022

          Bladder Cancer, Recurrent Bladder Cancer, FGFR3 Gene Mutation Trial in United States (Erdafitinib)

          Recruiting
          • Bladder Cancer
          • +2 more
          • Basking Ridge, New Jersey
          • +6 more
          Aug 22, 2022

          Non-Muscle Invasive Bladder Cancer, Self Efficacy, Smoking Behaviors Trial in Istanbul (Behavioral: Motivational Interviewing

          Not yet recruiting
          • Non-Muscle Invasive Bladder Cancer
          • +4 more
          • Behavioral: Motivational Interviewing with WhatsApp video call
          • Istanbul, Turkey
            İrem Nur Ozdemir
          Jan 20, 2023

          Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

          Recruiting
          • Urothelial Carcinoma
          • +2 more
            • Recife, Pernambuco, Brazil
            • +6 more
            Jul 11, 2023

            Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

            Active, not recruiting
            • Non-muscle-invasive Bladder Cancer
            • Gemcitabine 1000 mg, Docetaxel 37.5g
            • Zagreb, Croatia
              University Hospital Centre Zagreb
            Jan 20, 2023

            Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer Trial (Cretostimogene Grenadenorepvec,

            Not yet recruiting
            • Non Muscle Invasive Bladder Cancer
            • +3 more
            • Cretostimogene Grenadenorepvec
            • n-dodecyl-B-D-maltoside
            • (no location specified)
            Oct 30, 2023

            Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

            Not yet recruiting
            • Muscle-Invasive Bladder Carcinoma
            • +2 more
            • Guangzhou, Guangdong, China
              Cancer Center, Sun Yat-sen University
            Aug 3, 2023

            Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)

            Recruiting
            • Non-muscle-invasive Bladder Cancer
            • Cairo, Egypt
              Mohamed Fawzy Salman
            Nov 19, 2022